Sabba Stephen L bought LGND
June 16, 2026 · Form 4 insider transaction
Sabba Stephen L bought 2,145 shares of Ligand Pharmaceuticals Incorporated at $66.13 per share, a transaction worth $141.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,145
Price
$66.13
Total value
$141.8K
InsiderSabba Stephen L
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 16, 2026
Filing dateJune 18, 2026
Shares owned after35,774
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These securities, as represented in Column 5, include the grant of 836 restricted shares approved by the Board of Directors of the Company at the 2026 Meeting held 5 June 2026, which shares were previously reported on a Form 4 for this Reporting Person dated 9 June 2026.